The College of American Pathologists (CAP) defines point-of-care
testing as testing performed at the site or near a patient with the result
leading to a possible change in the care of the patient. Lipid level in the
blood can be measured by point-of-care
lipid testing, which is used to measure cholesterol, low-density
lipoprotein, high-density lipoprotein, and triglycerides. The amount of time
consumed between diagnosis and treatment of a patient in hospitals, clinics,
ambulances, and patient homes is significantly reduced with POC tests.
Popularity of POCT is increasing due to timeliness, convenience, and potential
to improve patient outcomes. These tests are generally based on two detection
methods: antibody based and microbial particle based. A health care
professional or a nurse performs the test, analysis is performed, and lastly
the results are recorded. Tests include lateral flow immunochromatography,
enzyme-linked immunosorbent assays (ELISA), and agglutination test.
Strong
expertise with attention to detail makes our market research reports stand
apart, Request a Report sample @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25535
The health care industry has witnessed a major change in the
past few years due to emerging technological innovations including biosensors,
lab-on-a-chip, smartphone apps, and other wearable devices, contributing to a
closer connection with the patient- point-of care technologies due to which it
is becoming a part of the transformational healthcare landscape. Increase in
geriatric population, rise in prevalence of cardiovascular and diabetic
diseases, and increased health care awareness are the major drivers of the
market. Other factors augmenting the market are recent technological
advancements, user-friendliness, and accuracy. Unhealthy and sedentary lifestyle
habits are anticipated to provide new entrants with a wider user group.
Improved technology, lab automation to provide cheaper, accurate, and high
quality results, and increased home care facilities with rapid and effective
diagnostic results also contribute to the growth of the point-of care lipid
testing market. Rapidly increasing cost of POC lipid testing and stringent and
time-consuming ambiguous regulatory frameworks are expected to hamper market
growth during the forecast period. Rural locations with limited lab services
and shortage of trained laboratory workers present an opportunity for new
entrants in developing countries.
Pre Book Point of Care (POC) Lipid Testing Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=25535<ype=S
Based on product type, the POC lipid testing market has been
segmented into consumables and instruments. In terms of application, the market
has been segmented into hypertriglyceridemia, hyperlipoproteinemia, Tangier
disease, hyperlipidemia, familial hypercholesterolemia, and others. Based on
end-user, the POC lipid testing market has been segmented into hospitals,
clinical diagnostic laboratories, and home care settings.
POC lipid
testing consumables are inexpensive, easy to handle, and primarily used by the
geriatric population, triggering the growth of POC lipid testing in homecare
setting due to which this segment is anticipated to grow significantly. The
hospitals segment is projected to account for significant share of the POC
lipid testing market due to availability of trained professionals and advanced
medical infrastructure. Sedentary lifestyle and high fat diet contribute to the
increasing incidence of hyperlipidemia followed by hypertriglyceridemia leading
to cardiovascular diseases, thus for the management of critical cardiovascular
conditions the use of PoC lipid testing device is rising in hospitals.
Request COVID Analysis on Point of Care (POC) Lipid Testing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=25535
In terms
of region, the POC lipid testing market has been segmented into North America,
EMEA, and Asia Pacific. According to European cardiovascular disease statistics
(2017), CVD accounts for 45% of all the deaths in Europe and 35% of all deaths
in the EU. Europe is anticipated to be the largest market for POC lipid testing
due to high prevalence of CVD, development of hospital infrastructure, and
favorable regulations. Asia Pacific is likely to be the next major market due
to rapid development and increase in demand for diagnostic testing in countries
such as China and India. The market is primarily dominated by established
companies which has increase competition in terms of pricing, distribution
partnership, and upgrade of products and technology.
Key players
in the POC lipid testing market include Alere, Inc., Abaxis, Inc., Polymer
Technology Systems, Roche Diagnostics, Samsung Electronics Corporation, Bio-Rad
Laboratories, The Menarini Group, and Nova Biomedical.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to industry leaders, consultants, and
strategy professionals.
Our reports are single-point solutions for industries to grow, evolve,
and mature. Our significant-time data collection methods along with ability to
track more than one million high growth niche products are aligned with your
aims. The detailed and proprietary statistical models used by our analysts
offer insights for making right decision in the shortest span of time. For
organizations that require specific but comprehensive information we offer
customized solutions through adhoc reports. These demands are delivered with
the perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for client-specific problems
with right methodology of research is the key to help enterprises reach right
decision.
U.S. Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
